Gf Fund Management Co. Ltd. Pyxis Oncology, Inc. Transaction History
Gf Fund Management Co. Ltd.
- $4.97 Trillion
- Q2 2025
A detailed history of Gf Fund Management Co. Ltd. transactions in Pyxis Oncology, Inc. stock. As of the latest transaction made, Gf Fund Management Co. Ltd. holds 1,429 shares of PYXS stock, worth $3,515. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,429
Previous 1,429
-0.0%
Holding current value
$3,515
Previous $1.4 Million
12.29%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding PYXS
# of Institutions
74Shares Held
22.9MCall Options Held
0Put Options Held
0-
Laurion Capital Management LP New York, NY3.63MShares$8.92 Million0.07% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.54MShares$8.71 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.79MShares$6.85 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA2.5MShares$6.15 Million0.16% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.15MShares$5.29 Million0.0% of portfolio
About Pyxis Oncology, Inc.
- Ticker PYXS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,096,400
- Market Cap $86.3M
- Description
- Pyxis Oncology, Inc., a preclinical stage biopharmaceutical company, engages in the development of therapies to treat cancers. Its immune-oncology product candidates include PYX-106, an investigational fully human immunoglobulin G1 isotype siglec-15 targeting antibody for the treatment of thyroid cancer, head and neck squamous cell carcinoma, no...